Navigation Links
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
Date:1/25/2008

SAN DIEGO, Jan. 25 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that Merck & Co., Inc. initiated a Phase 1 clinical trial of a second generation oral niacin receptor agonist under a collaboration between the companies to discover drugs for the treatment of atherosclerosis and other disorders. The initiation of this trial does not trigger a milestone payment.

"We are very pleased with the progress of this collaboration investigating the therapeutic potential of niacin receptor agonists to treat atherosclerosis and other disorders. We are looking forward to the Phase 1 results and the continued progress of the program," said Jack Lief, Arena's President and Chief Executive Officer.

Arena also announced that preclinical investigation of MK-0354, a first generation niacin receptor agonist being evaluated for indications other than atherosclerosis, was discontinued for compound specific reasons.

About Atherosclerosis

Atherosclerosis is characterized by the collection of fatty material deposits, such as cholesterol, along artery walls. This fatty material thickens, hardens, and may eventually block the arteries, adversely affecting blood flow and increasing the risk of heart attack and stroke over time. The American Heart Association estimates that atherosclerosis accounts for nearly 75% of all deaths from cardiovascular disease. HDL cholesterol, commonly known as the "good" cholesterol, can help clear the fatty deposits from the walls of blood vessels and transport cholesterol to the liver for processing and removal from the body. Drugs that can influence the levels of HDL cholesterol, or "good" cholesterol, may potentially provide clinical benefits to patients by reducing the
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
2. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
3. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
4. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
9. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
10. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
11. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Missouri (PRWEB) May 23, 2013 ... manufacture of complete thermal systems, recently introduced its ... 90 years of experience in designing and manufacturing ... selection of products to serve diverse customer needs. ... is featured at the beginning of the book. ...
(Date:5/22/2013)... 22, 2013 iLuv Creative Technology, the ... for the mobile lifestyle, announces they are now shipping ... manage multiple iPad devices efficiently. Winner of the 2013 ... Good Design award, MultiCharger-X is revolutionizing the way businesses, ... is deployed. , MultiCharger-X (iAD910) combines ...
(Date:5/22/2013)... , May 22, 2013  Superior Controls, ... Year 2013" by Business NH Magazine.  For the ... State organizations that distinguish themselves with extraordinary business ... proud to receive this honor," said ...  "As with any recognition, this award is a ...
(Date:5/22/2013)... Mold remediation could take a toll on one's pocket. ... to cut down the process' expense. And so, to help ... of a method how to kill mold effectively ... My Cleaning Products said. But in case mold gets past ... must then be promptly implemented as it poses several health ...
Breaking Biology Technology:Watlow Introduces Its New Industrial Heater Catalog 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2
... Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma" or, the "Company") is ... the nine month period ended February 28, 2009.Financial highlights include: , ... Sales revenue increased to US $2,715,702 for the nine months ended ... February 29, 2008. , ...
... Susan Weinschenk is Chief of Technical Staff and Services of ... design services. Dr. Weinschenk recently released her latest book ... What makes them click? Colleagues, usability professionals, ... Accolades about her book and her recent appearances have been ...
... To Legislature Calls For Rejection Of Legislation That Will ... In testimony to the Legislature and a full ... biotechnology association warned that a bill under consideration by ... onerous regulatory environment for biotechnology growth and development not ...
Cached Biology Technology:Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009 2Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at 'Persuasive Technologies 2009 Conference' and 'Voices That Matter Web Design Conference' 2Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences 2
(Date:5/22/2013)... environmental and human health effects from disposal of ... led scientists to recommend stronger government policies to ... battery materials. That,s the conclusion of a new ... & Technology . , Oladele A. Ogunseitan and ... mainstays for powering everything from smart phones to ...
(Date:5/22/2013)... Irvine, Calif., May 22, 2013 Early screening for ... personal pregnancy testing is for women, thanks to UC ... the American Chemical Society . , After more than ... a way to clearly identify clinically usable markers for ... be detected far sooner, with greater accuracy and at ...
(Date:5/21/2013)... device attached to a whale entangled in fishing gear, ... changed a whale,s diving and swimming behavior. The monitoring ... and migrate, depletes their energy as they drag gear ... slow death. , The scientists in this entanglement response ... two-year-old female North Atlantic right whale called Eg 3911. ...
Breaking Biology News(10 mins):UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3
... drier conditions to come Human-induced climate change ... To assess whether the onset of drier conditions ... multicentury tree ring records from Tunisia and Algeria for ... a new set of 13 chronologies from Atlas cedars ...
... of you is turning yellow. Do you gun the engine ... for their green, or do you slow down and wait ... according to new research from Tel Aviv University. Arnon Lotem, ... Aviv University, reports in the prestigious journal Nature that people ...
... researchers are investigating exactly how chemotherapy drugs kill cancerous ... test the effectiveness of safer new agents. , Dr Stephen ... Faculty of Life Sciences have taken a new systematic ... for breast or ovarian cancer in the UK. ...
Cached Biology News:AGU journal highlights -- August 6, 2008 2AGU journal highlights -- August 6, 2008 3AGU journal highlights -- August 6, 2008 4AGU journal highlights -- August 6, 2008 5AGU journal highlights -- August 6, 2008 6AGU journal highlights -- August 6, 2008 7Humans' response to risk can be unnecessarily dangerous, finds Tel Aviv University study 2How chemo kills tumors: research to reduce side effects 2How chemo kills tumors: research to reduce side effects 3
... Dyad instrument is the most advanced thermal ... world-class thermal performance, the Dyad also boasts ... as point-and-click navigation via touch pad or ... easily and economically expanded to a four-bay ...
...
Kit for testing the ability of a compound to simulate lipolysis in cultured human adipocytes. Kit contains controls, buffers and reagents for detecting glycerol and non-esterified free fatty acids. A...
... Experion Pro260 analysis kit for 10 chips ... perform protein analysis with the Experion automated ... microfluidic chips, 3 x 520 microliters Pro260 ... Pro260 ladder (10-260 kD), 400 microliters Pro260 ...
Biology Products: